News and notes from the day in MedCity, Ohio:
Northeast Ohio’s economy has been more similar to the U.S. economy during the current recession than in the 1981 recession, thanks in part to growth in the region’s biomedical industry, according to the most recent edition of Team NEO’s quarterly Cleveland Plus Economic Review.
Medpace, the privately held clinical research organization in Cincinnati, has acquired for undisclosed terms Medical Consulting Dr. Schlichtiger GmbH, a Munich, Germany, CRO that handles regulatory submissions and approvals, as well as drug safety management and reporting for pharmaceutical, biotechnology and nutritional companies in Europe, according to a Marketwire release.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Neoprobe Corp., the Dublin company developing novel cancer-detection drugs, has posted online (pdf) its Jan. 12 presentation at the annual OneMedPlace Financial Forum in San Francisco.
Kent State University nursing professor and Fulbright Fellow Donna Martsolf, who helped create the Kent State University College of Nursing in the Haitian town of Leogane in 2004, witnessed that country’s devastating earthquake last week and is telling how the college’s nurses are helping fellow residents, the Cleveland Plain Dealer and WKSU-FM reported.
Access HealthColumbus, the West Ohio Conference of the United Methodist Church and several other groups, including the four Columbus hospital systems and several foundations, are partnering to open a “pharmacy of last resort” for the poor inside the Livingston United Methodist Church, according to the Columbus Dispatch.
Kent State University employee Diana Heldt is recovering from near-complete paralysis at Altercare in Brimfield, however that could change Tuesday when Cleveland health insurer Medical Mutual of Ohio decides whether it will continue paying for her therapy, according to the Kent-Ravenna Record-Courier.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Scientists like Bruce Trapp, head of the neurosciences department at the Cleveland Clinic’s Lerner Research Institute, are tantalized by signs the body can create new myelin, a fatty substance that protects nerve fibers and is damaged by attacks brought on by multiple sclerosis, according to the Wall Street Journal.
